Drugs / Novarel
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05571111 Comparator | Oct 2022 → Mar 2024 | infertility disorder | Ferring Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novarel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05571111 ↗ |
| Route | Subcutaneous | “Subcutaneous injection as a single dose. 10,000 IU (1 mL)” NCT05571111 ↗ |